메뉴 건너뛰기
European Heart Journal
Volumn 23, Issue 5, 2002, Pages 425-426
Chronic heart failure guidelines [2]
Author keywords

[No Author keywords available]
Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;
EID: 0036522178     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3012     Document Type: Letter
Times cited : (1)
References (3)
  • 1
    • 17944374924 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of chronic heart failure
    • Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
    • (2001) Eur Heart J , vol.22 , pp. 1527-1560
    • Remme, W.J.1    Swedberg, K.2
  • 2
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3
  • 3
    • 0030587794 scopus 로고    scopus 로고
    • Effectiveness of spironolactone added to an ACE inhibitor and a loop diuretic for severe chronic heart failure
    • The RALES investigators. Effectiveness of spironolactone added to an ACE inhibitor and a loop diuretic for severe chronic heart failure. Am J Cardiol 1996; 78: 902-7.
    • (1996) Am J Cardiol , vol.78 , pp. 902-907

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.